Vitamin E (also called tocopherol) is a fat-soluble vitamin whose main function is to protect cells from oxidative damage in cell membranes and other lipid compartments of the body (an officially authorized claim at the European level). The name "vitamin E" actually groups together eight different molecules (four tocopherols and four tocotrienols), although the form with the highest documented biological activity is alpha-tocopherol. This page covers how it acts, the different isoforms, its food sources, the studied doses, the precautions (including a caveat about megadoses) and where it fits within the Pleniage portfolio.
What is vitamin E?
Vitamin E is a fat-soluble (soluble in fats) vitamin essential for human beings. Unlike other vitamins, "vitamin E" is not a single molecule but a family of eight related compounds: four tocopherols (α, β, γ, δ) and four tocotrienols (α, β, γ, δ). They all share a basic chemical structure (a chromanol ring with a side chain) and they all act as fat-soluble antioxidants, although they differ in biological potency and bioavailability.
Of these eight isoforms, alpha-tocopherol (α-tocopherol) is the form with the highest documented biological activity in humans and the only one recognized in European nutritional reference values. It is the form usually used in commercial supplements and the one that has been studied most extensively.
The name "tocopherol" comes from the Greek tokos ("birth") and pherein ("to carry") and reflects the early observations from the 1920s about its role in the fertility of animal models. Today we know that its fundamental biological function is to be one of the main fat-soluble antioxidants of the body.
What is it for? Function authorized at the European level
At the European level, the EFSA (European Food Safety Authority) has evaluated the physiological functions of vitamin E and has officially authorized one health claim:
Protection of cells from oxidative stress
Vitamin E contributes to the protection of cells from oxidative stress (authorized EFSA claim, ID 160). This function reflects its central role as a fat-soluble antioxidant in cell membranes: vitamin E neutralizes free radicals that affect membrane lipids, preventing lipid peroxidation and preserving the structural integrity of cell and mitochondrial membranes.
Unlike other vitamins that have multiple authorized green EFSA claims (vitamin C has 9, magnesium 10), vitamin E has a single green claim. This difference does not imply that vitamin E is less important: it means that the EFSA, in its rigorous evaluation, considered that the body of scientific evidence supported with sufficient robustness only this specific function as an authorized claim for the labelling and communication of food supplements.
How it acts: fat-soluble antioxidant of membranes
Vitamin E exerts its antioxidant function in cell and mitochondrial membranes, the lipid compartments of the body. Its mechanism is as follows:
- Scavenging of lipid radicals: when the polyunsaturated fatty acids of the membranes are attacked by free radicals, vitamin E (specifically its chromanol group) donates an electron to the radical, neutralizing it. This process prevents the propagation of lipid peroxidation (the oxidation chain that would progressively damage the entire membrane).
- Generation of the α-tocopheroxyl radical: upon donating the electron, vitamin E itself remains in a relatively stable oxidized form.
- Recycling via vitamin C: the α-tocopheroxyl radical can be reduced back to active α-tocopherol thanks to vitamin C (which acts as an electron donor from the aqueous phase). This synergy between vitamin E (fat-soluble) and vitamin C (water-soluble) is recognized in a specific EFSA claim for vitamin C (ID 139: "regeneration of the reduced form of vitamin E").
This synergy explains why many antioxidant formulations include both vitamins together: they work in different cellular compartments (membranes and cytoplasm respectively) but recycle one another.
The eight isoforms: tocopherols and tocotrienols
The structural diversity of the "vitamin E" family is relevant to understanding the labelling of supplements:
| Family | Isoforms | Notes |
|---|---|---|
| Tocopherols (saturated side chain) | α, β, γ, δ | α-tocopherol is the form with the highest recognized biological activity. γ-tocopherol is abundant in soybean and corn oils but its biological activity is lower. |
| Tocotrienols (side chain with three double bonds) | α, β, γ, δ | Rarer in foods. Emerging research on additional biological activities (cardiovascular, anti-inflammatory), not yet consolidated as EFSA claims. |
α-tocopherol in turn exists in two stereochemical forms: RRR-α-tocopherol (the natural form, the only one that appears in foods) and all-rac-α-tocopherol (a synthetic mixture of eight stereoisomers, more economical to produce and widely used in generic supplements). The natural RRR form has approximately twice the bioavailability per milligram compared to the synthetic all-rac form.
Food sources and daily requirements
Vitamin E is present above all in vegetable oils and nuts. The sources with the highest concentration are:
- Wheat germ oil: the most concentrated source (approximately 150 mg/100g).
- Sunflower and corn oil: common sources in Spanish cooking.
- Extra virgin olive oil: provides vitamin E together with polyphenols and monounsaturated fatty acids.
- Nuts, especially hazelnuts, almonds and pine nuts.
- Sunflower seeds and other oilseeds.
- Avocado.
- Green leafy vegetables (spinach, broccoli) in smaller amounts.
- Egg yolk and oily fish in modest amounts.
The nutrient reference value (NRV) in the European Union for vitamin E is 12 mg/day of α-tocopherol equivalents (EU Regulation 1169/2011 on food information). International recommendations for adults are around 15 mg/day.
Studied doses and commercial forms
Vitamin E supplements typically provide between 30 and 400 IU per dose (international units are the old labelling convention: 1 mg of RRR-α-tocopherol equals 1.49 IU; 1 mg of all-rac-α-tocopherol equals 1 IU). The highest doses (400-1,000 IU/day) have been used in clinical studies on chronic diseases, and it is in these contexts that the warnings about megadoses discussed in the following section have arisen.
The most common commercial forms are:
- D-α-tocopherol (RRR-α-tocopherol): the natural form, higher bioavailability.
- DL-α-tocopherol (all-rac-α-tocopherol): the synthetic form, a mixture of stereoisomers, more economical.
- Tocopheryl acetate or succinate: esters that are more stable in storage; they are hydrolysed in the intestine to release the active tocopherol.
- Mixed tocopherols: include α + β + γ + δ tocopherols. Closer to the natural dietary profile.
- Tocotrienols: more recent and specialized formulations.
About megadoses: an important warning
This section deserves an explicit statement for a regulatory and safety reason.
A meta-analysis published in 2005 in Annals of Internal Medicine by Miller et al., which synthesized 19 clinical trials with a total of more than 135,000 participants, found that supplementation with high doses of vitamin E (≥400 IU/day) over prolonged periods was associated with a moderate but statistically significant increase in all-cause mortality compared to placebo. This finding, although debated in subsequent literature, generated important changes in clinical recommendations: megadoses of vitamin E (≥400 IU/day) are NOT considered appropriate for general maintenance supplementation in healthy people.
Other large-scale studies (the SELECT trial, the HOPE trial) also raised unfavourable or null results for high-dose vitamin E supplementation in cardiovascular or cancer prevention. Current evidence holds that vitamin E is essential in usual dietary amounts and at the doses covered by the European NRV (12 mg/day) or slightly higher, but megadoses provide no documented additional benefit and may be counterproductive.
The practical conclusion is clear: for general maintenance supplementation, doses close to the NRV or moderately higher (15-30 mg/day) are appropriate. Megadoses (≥400 IU/day, equivalent to ≥267 mg/day of α-tocopherol) should be used only in specific clinical contexts and under medical supervision.
Safety and interactions
At the NRV doses or moderately higher, vitamin E has a favourable safety profile. The EFSA has established a tolerable upper intake level (UL) of 300 mg/day of α-tocopherol from food supplements (not counting the vitamin E from the diet).
Anticoagulant effect (important)
Vitamin E at high doses (≥300 mg/day) has an antiplatelet effect that can potentiate the effect of anticoagulant or antiplatelet medication (warfarin, acetylsalicylic acid, clopidogrel) and increase the risk of bleeding. It is the most relevant pharmacological interaction of vitamin E. People on chronic anticoagulant treatment should consult their doctor before supplementing with vitamin E.
Scheduled surgery
Because of the anticoagulant effect mentioned, it is recommended to discontinue vitamin E supplementation at least 2 weeks before any scheduled surgical procedure.
Other precautions
- Chemotherapy and radiotherapy: people undergoing oncological treatment should consult their oncologist before any supplementation with antioxidants.
- Pregnancy and breastfeeding: doses within the usual range of the vitamin complex are safe; megadoses are not advised.
How to choose a vitamin E supplement
- Dose close to the NRV: 12-30 mg/day of α-tocopherol equivalents is appropriate for general maintenance. Avoid megadoses except on medical prescription.
- Natural D-α-tocopherol form: higher bioavailability per milligram than the synthetic DL-α-tocopherol form.
- Mixed tocopherols: if available and a profile closer to the natural dietary one is sought, supplements with α + β + γ + δ tocopherols are a reasonable option.
- Consistency with the antioxidant complex: vitamin E is usually combined with vitamin C (synergy of α-tocopheroxyl recycling, EFSA claim ID 139), magnesium and B-group vitamins in general support formulas.
- Purity and traceability: third-party certificates of analysis when available.
Vitamin E in the Pleniage portfolio
In the formulation of PLENIAGE® ENERGY PRO, vitamin E is incorporated together with vitamin C, a complete B complex (B1, B2, B3, B5, B6, B12), magnesium citrate, alpha-lipoic acid (175 mg) and biotin. This combination is consistent with the documented synergy between vitamin E (fat-soluble antioxidant of membranes) and vitamin C (which regenerates oxidized α-tocopherol, EFSA claim ID 139), and with the integration of vitamin E into a broad antioxidant complex. The doses are within the range of the NRV or moderately higher, far from the megadoses with a less favourable safety profile. Each ingredient has its own individual scientific research; the specific combination of this formula has not been the subject of its own clinical trial.
This page is part of the Energy and performance cluster. To explore other related components in more depth, see the Vitamin C page (direct biochemical synergy) and the Alpha-lipoic acid page (another antioxidant in the formula).
Frequently asked questions about vitamin E
Why does vitamin E have only one green EFSA claim, compared to 9 for vitamin C?
The EFSA evaluates each proposed claim independently and rigorously, requiring scientific evidence that supports the cause-effect relationship between the substance and the claimed function. Vitamin E has a very clear main biological function (fat-soluble antioxidant of membranes, claim ID 160), and other proposed functions did not reach the level of evidence required by the EFSA for authorization. This does NOT imply that vitamin E is biologically less important: its specific function is essential and unique.
What is the difference between a tocopherol and a tocotrienol?
Both belong to the "vitamin E" family. Tocopherols have a saturated side chain and are the most abundant forms in foods (especially α-tocopherol). Tocotrienols have a side chain with three double bonds and are rarer in foods. The form with the highest biological activity recognized and authorized by European regulations is α-tocopherol. Tocotrienols are the subject of emerging research on additional biological activities, but they have not yet been consolidated as specific EFSA claims.
How much vitamin E do I need per day?
The nutrient reference value (NRV) in the European Union is 12 mg/day of α-tocopherol equivalents. International recommendations for adults are around 15 mg/day. For general maintenance supplementation, doses close to the NRV or moderately higher (15-30 mg/day) are appropriate. The EFSA has established a tolerable upper intake level (UL) of 300 mg/day from food supplements.
Are megadoses of vitamin E safe?
Not for general maintenance supplementation. A meta-analysis published in 2005 in Annals of Internal Medicine (Miller et al.) that synthesized 19 trials with more than 135,000 participants found that supplementation with high doses (≥400 IU/day) was associated with a moderate but significant increase in all-cause mortality. Megadoses are NOT considered appropriate for healthy people and should be reserved for specific clinical contexts under medical supervision.
Is natural vitamin E better than synthetic?
Yes, in terms of bioavailability per milligram. Natural vitamin E (D-α-tocopherol or RRR-α-tocopherol, present in foods) has approximately twice the bioavailability of the synthetic form (DL-α-tocopherol or all-rac-α-tocopherol, a mixture of eight stereoisomers). Professional-grade supplements usually use the natural form; cheap generic supplements usually use the synthetic one. The labelling declares the form used.
Does vitamin E have contraindications?
Yes, several relevant ones. Vitamin E at high doses has an antiplatelet effect that can potentiate anticoagulant medication (warfarin, ASA, clopidogrel) and increase the risk of bleeding. It is recommended to discontinue supplementation at least 2 weeks before any scheduled surgery. People undergoing oncological treatment should consult their oncologist. Megadoses (≥400 IU/day) are not recommended for general maintenance because of the association with increased mortality documented in the Miller 2005 meta-analysis.
Why is vitamin E combined with vitamin C in many supplements?
Because of a documented biochemical synergy that is officially recognized by the EFSA. Vitamin E is a fat-soluble antioxidant that acts in cell membranes; when it neutralizes free radicals it remains in an oxidized form (the α-tocopheroxyl radical). Vitamin C, a water-soluble antioxidant, can regenerate oxidized vitamin E by returning it to its active form, which is recognized in EFSA claim ID 139 ("vitamin C contributes to the regeneration of the reduced form of vitamin E"). This synergy justifies their common combination in antioxidant formulations.
Vitamin E is an essential fat-soluble vitamin whose main function authorized at the European level is the protection of cells from oxidative stress (EFSA claim ID 160). This name groups together eight isoforms (four tocopherols + four tocotrienols), with α-tocopherol being the form with the highest recognized biological activity. Its most robust clinical evidence supports its role as a fat-soluble antioxidant of membranes, in synergy with vitamin C which regenerates it when oxidized (EFSA claim ID 139). For general maintenance supplementation, doses close to the European NRV (12 mg/day) or moderately higher are appropriate; megadoses (≥400 IU/day) have been associated with unfavourable effects in the Miller 2005 meta-analysis and should be reserved for specific clinical contexts under medical supervision.
At PLENIAGE® we publish scientific content on evidence-based supplementation. You can explore the Energy and performance cluster for more related pages and articles.
References
The statements in the article are based on available scientific literature and on the health claims officially authorized by the EFSA.
- EFSA Health Claims Register — vitamin E: authorized claim ID 160 (protection of cells from oxidative stress). Official source: EU Register of Nutrition and Health Claims.
- EU Regulation 1169/2011 on food information to consumers — Annex XIII (NRV for vitamin E: 12 mg/day). EFSA UL for supplements: 300 mg/day of α-tocopherol.
- Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142(1):37-46. PMID: 15537682.
- Traber MG, Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic Biol Med. 2007;43(1):4-15. PMID: 17561088.
- Sen CK, Khanna S, Roy S. Tocotrienols: Vitamin E beyond tocopherols. Life Sci. 2006;78(18):2088-2098. PMID: 16458936.